Treatment of tuberculosis must be analysed for relative cost effectiveness of inpatient and outpatient models of care as it will benefit regions where tuberculosis is highly prevalent. Unless there is severe complications it is highly recommended to treat the TB patient in ambulatory care rather than inpatient services.
Multi-drug-resistant tuberculosis cost-effectiveness of therapy
Tuberculosis cost-effectiveness of therapy
Pneumoconiosis cost-effectiveness of therapy
Multi-drug-resistant tuberculosis secondary prevention
Bacterial pneumonia cost-effectiveness of therapy
Pneumonia cost-effectiveness of therapy
Multi-drug-resistant tuberculosis future or investigational therapies
Hospital-acquired pneumonia cost-effectiveness of therapy